LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: ADP-ribosylation of DNA and RNA.

    Groslambert, Joséphine / Prokhorova, Evgeniia / Ahel, Ivan

    DNA repair

    2021  Volume 105, Page(s) 103144

    Abstract: ADP-ribosylation is a chemical modification of macromolecules found across all domains of life and known to regulate a variety of cellular processes. Notably, it has a well-established role in the DNA damage response. While it was historically known as a ...

    Abstract ADP-ribosylation is a chemical modification of macromolecules found across all domains of life and known to regulate a variety of cellular processes. Notably, it has a well-established role in the DNA damage response. While it was historically known as a post-translational modification of proteins, recent studies have shown that nucleic acids can also serve as substrates of reversible ADP-ribosylation. More precisely, ADP-ribosylation of DNA bases, phosphorylated DNA ends and phosphorylated RNA ends have been reported. We will discuss these three types of modification in details. In a variety of bacterial species, including Mycobacterium tuberculosis, ADP-ribosylation of thymidine has emerged as the mode of action of a toxin-antitoxin system named DarTG, with the resultant products perceived as DNA damage by the cell. On the other hand, mammalian DNA damage sensors PARP1, PARP2 and PARP3 were shown to ADP-ribosylate phosphorylated ends of double-stranded DNA in vitro. Additionally, TRPT1 and several PARP enzymes, including PARP10, can add ADP-ribose to the 5'-phosphorylated end of single-stranded RNA in vitro, representing a novel RNA capping mechanism. Together, these discoveries have led to the emergence of a new and exciting research area, namely DNA and RNA ADP-ribosylation, that is likely to have far-reaching implications for the fields of DNA repair, replication and epigenetics.
    MeSH term(s) ADP-Ribosylation ; Animals ; Cell Cycle Proteins/metabolism ; DNA/metabolism ; DNA Damage ; DNA Repair ; Humans ; Phosphorylation ; Poly (ADP-Ribose) Polymerase-1/metabolism ; Poly(ADP-ribose) Polymerases/metabolism ; Proto-Oncogene Proteins/metabolism ; RNA/metabolism
    Chemical Substances Cell Cycle Proteins ; Proto-Oncogene Proteins ; RNA (63231-63-0) ; DNA (9007-49-2) ; PARP1 protein, human (EC 2.4.2.30) ; PARP10 protein, human (EC 2.4.2.30) ; PARP2 protein, human (EC 2.4.2.30) ; PARP3 protein, human (EC 2.4.2.30) ; Poly (ADP-Ribose) Polymerase-1 (EC 2.4.2.30) ; Poly(ADP-ribose) Polymerases (EC 2.4.2.30)
    Language English
    Publishing date 2021-06-03
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2071608-4
    ISSN 1568-7856 ; 1568-7864
    ISSN (online) 1568-7856
    ISSN 1568-7864
    DOI 10.1016/j.dnarep.2021.103144
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Deregulated DNA ADP-ribosylation impairs telomere replication.

    Wondisford, Anne R / Lee, Junyeop / Lu, Robert / Schuller, Marion / Groslambert, Josephine / Bhargava, Ragini / Schamus-Haynes, Sandra / Cespedes, Leyneir C / Opresko, Patricia L / Pickett, Hilda A / Min, Jaewon / Ahel, Ivan / O'Sullivan, Roderick J

    Nature structural & molecular biology

    2024  

    Abstract: The recognition that DNA can be ADP ribosylated provides an unexpected regulatory level of how ADP-ribosylation contributes to genome stability, epigenetics and immunity. Yet, it remains unknown whether DNA ADP-ribosylation (DNA-ADPr) promotes genome ... ...

    Abstract The recognition that DNA can be ADP ribosylated provides an unexpected regulatory level of how ADP-ribosylation contributes to genome stability, epigenetics and immunity. Yet, it remains unknown whether DNA ADP-ribosylation (DNA-ADPr) promotes genome stability and how it is regulated. Here, we show that telomeres are subject to DNA-ADPr catalyzed by PARP1 and removed by TARG1. Mechanistically, we show that DNA-ADPr is coupled to lagging telomere DNA strand synthesis, forming at single-stranded DNA present at unligated Okazaki fragments and on the 3' single-stranded telomere overhang. Persistent DNA-linked ADPr, due to TARG1 deficiency, eventually leads to telomere shortening. Furthermore, using the bacterial DNA ADP-ribosyl-transferase toxin to modify DNA at telomeres directly, we demonstrate that unhydrolyzed DNA-linked ADP-ribose compromises telomere replication and telomere integrity. Thus, by identifying telomeres as chromosomal targets of PARP1 and TARG1-regulated DNA-ADPr, whose deregulation compromises telomere replication and integrity, our study highlights and establishes the critical importance of controlling DNA-ADPr turnover for sustained genome stability.
    Language English
    Publishing date 2024-05-07
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2126708-X
    ISSN 1545-9985 ; 1545-9993
    ISSN (online) 1545-9985
    ISSN 1545-9993
    DOI 10.1038/s41594-024-01279-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The interplay of TARG1 and PARG protects against genomic instability.

    Groslambert, Joséphine / Prokhorova, Evgeniia / Wondisford, Anne R / Tromans-Coia, Callum / Giansanti, Celeste / Jansen, Jennifer / Timinszky, Gyula / Dobbelstein, Matthias / Ahel, Dragana / O'Sullivan, Roderick J / Ahel, Ivan

    Cell reports

    2023  Volume 42, Issue 9, Page(s) 113113

    Abstract: The timely removal of ADP-ribosylation is crucial for efficient DNA repair. However, much remains to be discovered about ADP-ribosylhydrolases. Here, we characterize the physiological role of TARG1, an ADP-ribosylhydrolase that removes aspartate/ ... ...

    Abstract The timely removal of ADP-ribosylation is crucial for efficient DNA repair. However, much remains to be discovered about ADP-ribosylhydrolases. Here, we characterize the physiological role of TARG1, an ADP-ribosylhydrolase that removes aspartate/glutamate-linked ADP-ribosylation. We reveal its function in the DNA damage response and show that the loss of TARG1 sensitizes cells to inhibitors of topoisomerase II, ATR, and PARP. Furthermore, we find a PARP1-mediated synthetic lethal interaction between TARG1 and PARG, driven by the toxic accumulation of ADP-ribosylation, that induces replication stress and genomic instability. Finally, we show that histone PARylation factor 1 (HPF1) deficiency exacerbates the toxicity and genomic instability induced by excessive ADP-ribosylation, suggesting a close crosstalk between components of the serine- and aspartate/glutamate-linked ADP-ribosylation pathways. Altogether, our data identify TARG1 as a potential biomarker for the response of cancer cells to PARP and PARG inhibition and establish that the interplay of TARG1 and PARG protects cells against genomic instability.
    MeSH term(s) Humans ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology ; Aspartic Acid/metabolism ; ADP-Ribosylation ; Genomic Instability ; Glutamates/metabolism ; Carrier Proteins/metabolism ; Nuclear Proteins/metabolism
    Chemical Substances Poly(ADP-ribose) Polymerase Inhibitors ; Aspartic Acid (30KYC7MIAI) ; Glutamates ; HPF1 protein, human ; Carrier Proteins ; Nuclear Proteins
    Language English
    Publishing date 2023-09-06
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2023.113113
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities.

    Đukić, Nina / Strømland, Øyvind / Elsborg, Jonas Damgaard / Munnur, Deeksha / Zhu, Kang / Schuller, Marion / Chatrin, Chatrin / Kar, Pulak / Duma, Lena / Suyari, Osamu / Rack, Johannes Gregor Matthias / Baretić, Domagoj / Crudgington, Dorian Richard Kenneth / Groslambert, Joséphine / Fowler, Gerissa / Wijngaarden, Sven / Prokhorova, Evgeniia / Rehwinkel, Jan / Schüler, Herwig /
    Filippov, Dmitri V / Sanyal, Sumana / Ahel, Dragana / Nielsen, Michael L / Smith, Rebecca / Ahel, Ivan

    Science advances

    2023  Volume 9, Issue 37, Page(s) eadi2687

    Abstract: PARP14 is a mono-ADP-ribosyl transferase involved in the control of immunity, transcription, and DNA replication stress management. However, little is known about the ADP-ribosylation activity of PARP14, including its substrate specificity or how PARP14- ... ...

    Abstract PARP14 is a mono-ADP-ribosyl transferase involved in the control of immunity, transcription, and DNA replication stress management. However, little is known about the ADP-ribosylation activity of PARP14, including its substrate specificity or how PARP14-dependent ADP-ribosylation is reversed. We show that PARP14 is a dual-function enzyme with both ADP-ribosyl transferase and hydrolase activity acting on both protein and nucleic acid substrates. In particular, we show that the PARP14 macrodomain 1 is an active ADP-ribosyl hydrolase. We also demonstrate hydrolytic activity for the first macrodomain of PARP9. We reveal that expression of a PARP14 mutant with the inactivated macrodomain 1 results in a marked increase in mono(ADP-ribosyl)ation of proteins in human cells, including PARP14 itself and antiviral PARP13, and displays specific cellular phenotypes. Moreover, we demonstrate that the closely related hydrolytically active macrodomain of SARS2 Nsp3, Mac1, efficiently reverses PARP14 ADP-ribosylation in vitro and in cells, supporting the evolution of viral macrodomains to counteract PARP14-mediated antiviral response.
    MeSH term(s) Humans ; Transferases ; Poly(ADP-ribose) Polymerase Inhibitors ; COVID-19 ; Antiviral Agents ; Hydrolases ; Poly(ADP-ribose) Polymerases/genetics
    Chemical Substances Transferases (EC 2.-) ; Poly(ADP-ribose) Polymerase Inhibitors ; Antiviral Agents ; Hydrolases (EC 3.-) ; PARP14 protein, human (EC 2.4.2.30) ; Poly(ADP-ribose) Polymerases (EC 2.4.2.30)
    Language English
    Publishing date 2023-09-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2810933-8
    ISSN 2375-2548 ; 2375-2548
    ISSN (online) 2375-2548
    ISSN 2375-2548
    DOI 10.1126/sciadv.adi2687
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Serine-linked PARP1 auto-modification controls PARP inhibitor response.

    Prokhorova, Evgeniia / Zobel, Florian / Smith, Rebecca / Zentout, Siham / Gibbs-Seymour, Ian / Schützenhofer, Kira / Peters, Alessandra / Groslambert, Joséphine / Zorzini, Valentina / Agnew, Thomas / Brognard, John / Nielsen, Michael L / Ahel, Dragana / Huet, Sébastien / Suskiewicz, Marcin J / Ahel, Ivan

    Nature communications

    2021  Volume 12, Issue 1, Page(s) 4055

    Abstract: Poly(ADP-ribose) polymerase 1 (PARP1) and PARP2 are recruited and activated by DNA damage, resulting in ADP-ribosylation at numerous sites, both within PARP1 itself and in other proteins. Several PARP1 and PARP2 inhibitors are currently employed in the ... ...

    Abstract Poly(ADP-ribose) polymerase 1 (PARP1) and PARP2 are recruited and activated by DNA damage, resulting in ADP-ribosylation at numerous sites, both within PARP1 itself and in other proteins. Several PARP1 and PARP2 inhibitors are currently employed in the clinic or undergoing trials for treatment of various cancers. These drugs act primarily by trapping PARP1 on damaged chromatin, which can lead to cell death, especially in cells with DNA repair defects. Although PARP1 trapping is thought to be caused primarily by the catalytic inhibition of PARP-dependent modification, implying that ADP-ribosylation (ADPr) can counteract trapping, it is not known which exact sites are important for this process. Following recent findings that PARP1- or PARP2-mediated modification is predominantly serine-linked, we demonstrate here that serine ADPr plays a vital role in cellular responses to PARP1/PARP2 inhibitors. Specifically, we identify three serine residues within PARP1 (499, 507, and 519) as key sites whose efficient HPF1-dependent modification counters PARP1 trapping and contributes to inhibitor tolerance. Our data implicate genes that encode serine-specific ADPr regulators, HPF1 and ARH3, as potential PARP1/PARP2 inhibitor therapy biomarkers.
    MeSH term(s) ADP-Ribosylation ; Carrier Proteins/metabolism ; Cell Line ; Cell Line, Tumor ; DNA Damage ; DNA Repair ; Humans ; Neoplasms/drug therapy ; Neoplasms/enzymology ; Nuclear Proteins/metabolism ; Poly (ADP-Ribose) Polymerase-1/antagonists & inhibitors ; Poly (ADP-Ribose) Polymerase-1/metabolism ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology ; Poly(ADP-ribose) Polymerases/chemistry ; Poly(ADP-ribose) Polymerases/metabolism ; Protein Processing, Post-Translational ; Serine/metabolism
    Chemical Substances Carrier Proteins ; HPF1 protein, human ; Nuclear Proteins ; Poly(ADP-ribose) Polymerase Inhibitors ; Serine (452VLY9402) ; PARP1 protein, human (EC 2.4.2.30) ; PARP2 protein, human (EC 2.4.2.30) ; Poly (ADP-Ribose) Polymerase-1 (EC 2.4.2.30) ; Poly(ADP-ribose) Polymerases (EC 2.4.2.30)
    Language English
    Publishing date 2021-07-01
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-021-24361-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease

    Prokhorova, Evgeniia / Agnew, Thomas / Wondisford, Anne R. / Tellier, Michael / Kaminski, Nicole / Beijer, Danique / Holder, James / Groslambert, Josephine / Suskiewicz, Marcin J. / Zhu, Kang / Reber, Julia M. / Krassnig, Sarah C. / Palazzo, Luca / Murphy, Shona / Nielsen, Michael L. / Mangerich, Aswin / Ahel, Dragana / Baets, Jonathan / O’Sullivan, Roderick J. /
    Ahel, Ivan

    Molecular cell. 2021 June 17, v. 81, no. 12

    2021  

    Abstract: ARH3/ADPRHL2 and PARG are the primary enzymes reversing ADP-ribosylation in vertebrates, yet their functions in vivo remain unclear. ARH3 is the only hydrolase able to remove serine-linked mono(ADP-ribose) (MAR) but is much less efficient than PARG ... ...

    Abstract ARH3/ADPRHL2 and PARG are the primary enzymes reversing ADP-ribosylation in vertebrates, yet their functions in vivo remain unclear. ARH3 is the only hydrolase able to remove serine-linked mono(ADP-ribose) (MAR) but is much less efficient than PARG against poly(ADP-ribose) (PAR) chains in vitro. Here, by using ARH3-deficient cells, we demonstrate that endogenous MARylation persists on chromatin throughout the cell cycle, including mitosis, and is surprisingly well tolerated. Conversely, persistent PARylation is highly toxic and has distinct physiological effects, in particular on active transcription histone marks such as H3K9ac and H3K27ac. Furthermore, we reveal a synthetic lethal interaction between ARH3 and PARG and identify loss of ARH3 as a mechanism of PARP inhibitor resistance, both of which can be exploited in cancer therapy. Finally, we extend our findings to neurodegeneration, suggesting that patients with inherited ARH3 deficiency suffer from stress-induced pathogenic increase in PARylation that can be mitigated by PARP inhibition.
    Keywords cancer therapy ; chromatin ; histones ; human diseases ; hydrolases ; mitosis ; neurodegenerative diseases ; toxicity
    Language English
    Dates of publication 2021-0617
    Size p. 2640-2655.e8.
    Publishing place Elsevier Inc.
    Document type Article
    ZDB-ID 1415236-8
    ISSN 1097-4164 ; 1097-2765
    ISSN (online) 1097-4164
    ISSN 1097-2765
    DOI 10.1016/j.molcel.2021.04.028
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article ; Online: Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease.

    Prokhorova, Evgeniia / Agnew, Thomas / Wondisford, Anne R / Tellier, Michael / Kaminski, Nicole / Beijer, Danique / Holder, James / Groslambert, Josephine / Suskiewicz, Marcin J / Zhu, Kang / Reber, Julia M / Krassnig, Sarah C / Palazzo, Luca / Murphy, Shona / Nielsen, Michael L / Mangerich, Aswin / Ahel, Dragana / Baets, Jonathan / O'Sullivan, Roderick J /
    Ahel, Ivan

    Molecular cell

    2021  Volume 81, Issue 12, Page(s) 2640–2655.e8

    Abstract: ARH3/ADPRHL2 and PARG are the primary enzymes reversing ADP-ribosylation in vertebrates, yet their functions in vivo remain unclear. ARH3 is the only hydrolase able to remove serine-linked mono(ADP-ribose) (MAR) but is much less efficient than PARG ... ...

    Abstract ARH3/ADPRHL2 and PARG are the primary enzymes reversing ADP-ribosylation in vertebrates, yet their functions in vivo remain unclear. ARH3 is the only hydrolase able to remove serine-linked mono(ADP-ribose) (MAR) but is much less efficient than PARG against poly(ADP-ribose) (PAR) chains in vitro. Here, by using ARH3-deficient cells, we demonstrate that endogenous MARylation persists on chromatin throughout the cell cycle, including mitosis, and is surprisingly well tolerated. Conversely, persistent PARylation is highly toxic and has distinct physiological effects, in particular on active transcription histone marks such as H3K9ac and H3K27ac. Furthermore, we reveal a synthetic lethal interaction between ARH3 and PARG and identify loss of ARH3 as a mechanism of PARP inhibitor resistance, both of which can be exploited in cancer therapy. Finally, we extend our findings to neurodegeneration, suggesting that patients with inherited ARH3 deficiency suffer from stress-induced pathogenic increase in PARylation that can be mitigated by PARP inhibition.
    MeSH term(s) ADP-Ribosylation ; Adenosine Diphosphate Ribose/metabolism ; Cell Line, Tumor ; Chromatin ; DNA ; DNA Damage ; Fibroblasts/metabolism ; Glycoside Hydrolases/genetics ; Glycoside Hydrolases/metabolism ; Glycoside Hydrolases/physiology ; HEK293 Cells ; HeLa Cells ; Humans ; Poly ADP Ribosylation/physiology ; Poly Adenosine Diphosphate Ribose/metabolism ; Primary Cell Culture
    Chemical Substances Chromatin ; Adenosine Diphosphate Ribose (20762-30-5) ; Poly Adenosine Diphosphate Ribose (26656-46-2) ; DNA (9007-49-2) ; Glycoside Hydrolases (EC 3.2.1.-) ; ADPRS protein, human (EC 3.2.1.143) ; poly ADP-ribose glycohydrolase (EC 3.2.1.143)
    Language English
    Publishing date 2021-05-20
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1415236-8
    ISSN 1097-4164 ; 1097-2765
    ISSN (online) 1097-4164
    ISSN 1097-2765
    DOI 10.1016/j.molcel.2021.04.028
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top